MEN1 and gastrin-producing neuroendocrine tumor: The occurrence of germline MEN1 mutations in all patients with sporadic, non-familial parathyroid adenomas is 1%, in gastrinomas is 5%, in prolactinoma is 1%, and in foregut carcinoids is 2% (Thakker et al., 2012).